CMR Surgical
Founded Year
2014Stage
Series F | AliveTotal Raised
$1.351BRevenue
$0000Mosaic Score The Mosaic Score is an algorithm that measures the overall financial health and market potential of private companies.
+15 points in the past 30 days
About CMR Surgical
CMR Surgical focuses on surgical robotics for the healthcare industry. The company offers the Versius system, a surgical robot designed for minimally invasive surgery. CMR Surgical works with healthcare professionals to improve surgical procedures. CMR Surgical was formerly known as Cambridge Medical Robotics. It was founded in 2014 and is based in Cambridge, United Kingdom.
Loading...
ESPs containing CMR Surgical
The ESP matrix leverages data and analyst insight to identify and rank leading companies in a given technology landscape.
The surgical robots market involves the development and manufacturing of robotic systems used in minimally invasive surgical procedures. These systems allow surgeons to perform precise movements and access difficult-to-reach areas of the body with greater control, accuracy, and reduced risk of complications. This market is rapidly growing due to the increasing demand for minimally invasive surgeri…
CMR Surgical named as Outperformer among 15 other companies, including Zimmer Biomet, Medtronic, and Smith & Nephew.
Loading...
Research containing CMR Surgical
Get data-driven expert analysis from the CB Insights Intelligence Unit.
CB Insights Intelligence Analysts have mentioned CMR Surgical in 1 CB Insights research brief, most recently on Aug 9, 2022.
Expert Collections containing CMR Surgical
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
CMR Surgical is included in 5 Expert Collections, including Unicorns- Billion Dollar Startups.
Unicorns- Billion Dollar Startups
1,277 items
Robotics
2,703 items
This collection includes startups developing autonomous ground robots, unmanned aerial vehicles, robotic arms, and underwater drones, among other robotic systems. This collection also includes companies developing operating systems and vision modules for robots.
Artificial Intelligence
12,452 items
Companies developing artificial intelligence solutions, including cross-industry applications, industry-specific products, and AI infrastructure solutions.
Digital Health 50
150 items
The winners of the second annual CB Insights Digital Health 150.
Digital Health
11,398 items
The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma, sequencing instruments, gene editing, and assistive tech.
CMR Surgical Patents
CMR Surgical has filed 202 patents.
The 3 most popular patent topics include:
- surgery
- surgical instruments
- surgical robots
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
10/9/2020 | 2/25/2025 | Electrical engineering, Robotics, Mineralogy, Robotic manipulators, Automation | Grant |
Application Date | 10/9/2020 |
|---|---|
Grant Date | 2/25/2025 |
Title | |
Related Topics | Electrical engineering, Robotics, Mineralogy, Robotic manipulators, Automation |
Status | Grant |
Latest CMR Surgical News
Jun 19, 2025
London Stock Exchange welcomes CMR Surgical in celebration of its recent funding round of more than $200m London Stock Exchange 9 Jun 2025 Today, the London Stock Exchange welcomes CMR Surgical (CMR), the British-born global surgical robotics business, to participate in the market open ceremony in celebration of its recent funding round of more than $200m and its contribution to the UK’s manufacturing, technology and life sciences industry sectors. Founded and headquartered in Cambridge, the heart of Britain’s scientific and technology ecosystem, CMR is the company behind Versius, a versatile, adaptable, and digitally driven surgical robotic system dedicated to transforming surgery for patients globally. Versius is designed and manufactured in the UK. It is the second most utilised soft tissue surgical robot in the world and has been used to treat more than 30,000 patients globally across a broad range of specialities including colorectal, general, gynaecology, thoracic and urology. CMR’s latest fundraise, led by all its major shareholders, supports the company in its mission to bring the benefits of minimal access surgery to more patients around the world by fuelling the continuous development of the Versius system and its expansion into the vastly underserved worldwide robotic assisted surgery market. Massimiliano Colella, Chief Executive Officer of CMR commented: “We are honoured that the London Stock Exchange has chosen to feature CMR as a Great British scale-up success story and what better way to start London Tech Week than by celebrating British technology. As a MedTech company, CMR stands at the intersection of robotics, clinical excellence, and digital innovation. Our flagship platform, the Versius Surgical Robotic System, is a testament to how British-designed surgical robotics are shaping the future of minimal access surgery – not just in the UK, but worldwide.” Always active These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. Without these cookies, some parts of our site or the service being requested will be impossible to provide. Preferences Preferences The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user. Functional Cookies Functional Cookies The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you. Analytics Analytics The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
CMR Surgical Frequently Asked Questions (FAQ)
When was CMR Surgical founded?
CMR Surgical was founded in 2014.
Where is CMR Surgical's headquarters?
CMR Surgical's headquarters is located at Milton Road, Cambridge.
What is CMR Surgical's latest funding round?
CMR Surgical's latest funding round is Series F.
How much did CMR Surgical raise?
CMR Surgical raised a total of $1.351B.
Who are the investors of CMR Surgical?
Investors of CMR Surgical include Trinity Capital, Leading European Tech Scaleups, Cambridge Innovation Capital, Escala Capital, Watrium and 14 more.
Who are CMR Surgical's competitors?
Competitors of CMR Surgical include Origami Surgical, Asensus Surgical, Quantum Surgical, Momentis Surgical, Activ Surgical and 7 more.
Loading...
Compare CMR Surgical to Competitors
Asensus Surgical focuses on the development and manufacturing of digital laparoscopy and surgical robotics. The company's main offerings include the surgical system and the intelligent surgical unit. It primarily serves the healthcare industry, particularly the surgical technology sector. Asensus Surgical was formerly known as TransEnterix. It was founded in 2006 and is based in Durham, North Carolina. In August 2024, Asensus Surgical was acquired by Karl Storz.
Quantum Surgical is a medical device company that develops robotic-assisted technologies for cancer treatment within the interventional oncology sector. The company's main offering, the Epione® platform, is designed to plan, target, deliver, and confirm tumor ablation using robotics and image fusion technology. Quantum Surgical's solutions cater to the healthcare sector, providing tools for clinicians to perform procedures on inoperable or hard-to-reach tumors. It was founded in 2017 and is based in Montpellier, France.
Activ Surgical specializes in intraoperative surgical intelligence within the medical technology sector. The company's primary offering, ActivSight Intelligent Light, provides surgeons with real-time visual insights and information that reveal critical physiological structures and functions during surgery. Activ Surgical's products are designed to enhance surgical precision and patient care by integrating augmented reality, artificial intelligence, and machine learning technologies. Activ Surgical was formerly known as Omniboros, Inc. It was founded in 2017 and is based in Boston, Massachusetts.
Bionaut offers precision microtechnology within the healthcare sector. It develops microscale robots designed to deliver biologics or small molecule therapies locally to targeted disease areas, particularly for patients with severe brain disorders. Its micro-robots are navigated through the body using external magnetic propulsion for precise treatment and diagnostic purposes. It was founded in 2016 and is based in Los Angeles, California.
Theator operates within the healthcare technology sector and focuses on its Surgical Intelligence platform. The platform captures, manages, and analyzes surgical video data using AI to improve surgical quality and efficiency. It serves hospitals and healthcare providers and integrates surgical video with patient outcomes and operational analytics. It was founded in 2018 and is based in Palo Alto, California.
Body Vision Medical is a medical device company that specializes in AI-driven, real-time, intraoperative imaging within the healthcare sector. The company's main offering, the LungVision platform, provides imaging solutions for the diagnostics and treatment of lung cancer, aimed at enhancing diagnostic processes and clinical practices. Body Vision Medical serves the healthcare industry, particularly in pulmonology and related medical fields. It was founded in 2014 and is based in Weston, Massachusetts.
Loading...